These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31230179)

  • 1. Higher initial weight-based heparin dosing is required with direct oral anticoagulants during catheter ablation for atrial fibrillation.
    Payne JE; Koerber SM; Bickel T; Ghadban R; Flaker G; Gautam S
    J Interv Card Electrophysiol; 2020 Aug; 58(2):185-191. PubMed ID: 31230179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol driven periprocedural anticoagulation for left atrial ablation.
    Bradley CJ; Williamson BD; George J; Haines DE
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):639-646. PubMed ID: 33476459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant-treated patients.
    Martin AC; Lessire S; Leblanc I; Dincq AS; Philip I; Gouin-Thibault I; Godier A
    Clin Cardiol; 2018 May; 41(5):646-651. PubMed ID: 29532536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of different anticoagulation therapies on heparin dosage applied to atrial fibrillation patients undergoing atrial fibrillation catheter ablation].
    Yang L; Gao LJ; Yin XM; Guo BL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug; 47(8):602-607. PubMed ID: 31434430
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study.
    Bin Abdulhak AA; Kennedy KF; Gupta S; Giocondo M; Ramza B; Wimmer AP
    J Interv Card Electrophysiol; 2015 Nov; 44(2):91-6. PubMed ID: 26292959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE
    Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Intraprocedural Unfractionated Heparin Protocol During Catheter Ablation of Atrial Fibrillation in the Presence of Direct Oral Anticoagulants and Wide Spectrum of Body Mass Index.
    Safani M; Tobias S; Shandling AH; Redmond K; Lee MY
    J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):349-358. PubMed ID: 33749350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin.
    Konduru SV; Cheema AA; Jones P; Li Y; Ramza B; Wimmer AP
    J Interv Card Electrophysiol; 2012 Dec; 35(3):277-84; discussion 284. PubMed ID: 23015216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin.
    Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    J Cardiovasc Electrophysiol; 2018 Jun; 29(6):835-843. PubMed ID: 29533476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study.
    Calkins H; Willems S; Verma A; Schilling R; Hohnloser SH; Okumura K; Nordaby M; Kleine E; Bis B; Gerstenfeld EP
    Europace; 2019 Jun; 21(6):879-885. PubMed ID: 30982849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter ablation of left atrial arrhythmias on uninterrupted oral anticoagulation with vitamin K antagonists: What is the relationship between international normalized ratio, activated clotting time, and procedure-related complications?
    Kottmaier M; Bourier F; Semmler V; Telishevska M; Koch-Büttner K; Lennerz C; Lengauer S; Kornmayer M; Rousseva E; Brooks S; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I; Reents T
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1415-1422. PubMed ID: 28800176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a New Standardized Unfractionated Heparin Protocol for Left-Sided Ablation Procedures Improves Time in the Therapeutic ACT Range.
    Ural KG; Moridzadeh SS; Busch EH; Masri OE; Burton JH; Morin DP
    J Cardiothorac Vasc Anesth; 2024 Jan; 38(1):67-72. PubMed ID: 38030427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periprocedural and long-term safety and feasibility of direct oral anticoagulants in patients with biological valve undergoing radiofrequency catheter ablation for atrial fibrillation: a prospective multicenter study.
    Di Biase L; Romero J; Briceno D; Lakkireddy D; Trivedi C; Mohanty P; Mohanty S; Horton R; Hranitzky P; Gallinghouse GJ; Alviz I; Turagam M; Gopinathannair R; Della Rocca DG; Beheiry S; Burkhardt JD; Viles-Gonzales J; Natale A
    J Interv Card Electrophysiol; 2021 Sep; 61(3):617-622. PubMed ID: 32894399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel protocol for initial heparin administration during catheter ablation for atrial fibrillation in patients taking direct oral anticoagulants.
    Kishima H; Mine T; Fukuhara E; Ashida K; Ishihara M; Masuyama T
    Heart Vessels; 2019 May; 34(5):832-841. PubMed ID: 30390125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rivaroxaban on activated clotting time in catheter ablation for atrial fibrillation in Chinese patients.
    Songqun H; Chunling W; Zhifu G; Xinmiao H; Jiang C
    J Interv Card Electrophysiol; 2020 Dec; 59(3):509-516. PubMed ID: 31840206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation.
    Nagao T; Inden Y; Yanagisawa S; Kato H; Ishikawa S; Okumura S; Mizutani Y; Ito T; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Heart Rhythm; 2015 Sep; 12(9):1972-8. PubMed ID: 25881495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants.
    Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Komtasubara I; Kusachi S
    Clin Drug Investig; 2016 Oct; 36(10):837-48. PubMed ID: 27389243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes.
    Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2823-2833. PubMed ID: 31701593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of international normalized ratio and activated clotting time on unfractionated heparin dosing during ablation of atrial fibrillation.
    Hamam I; Daoud EG; Zhang J; Kalbfleisch SJ; Augostini R; Winner M; Tsai S; Rhodes TE; Houmsse M; Liu Z; Love CJ; Tyler J; Sachdev M; Weiss R; Hummel JD
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):491-6. PubMed ID: 23685538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study.
    Di Biase L; Gaita F; Toso E; Santangeli P; Mohanty P; Rutledge N; Yan X; Mohanty S; Trivedi C; Bai R; Price J; Horton R; Gallinghouse GJ; Beheiry S; Zagrodzky J; Canby R; Leclercq JF; Halimi F; Scaglione M; Cesarani F; Faletti R; Sanchez J; Burkhardt JD; Natale A
    Heart Rhythm; 2014 May; 11(5):791-8. PubMed ID: 24607716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.